Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

BACKGROUND: Available evidence suggests that adjunctive treatment with immunomodulatory medications may be effective in the treatment of major depressive disorder (MDD). A pilot trial of the tetracycline minocycline as adjunctive treatment in treatment-resistant depression (TRD), produced promising...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Psychiatry
Main Authors: Husain, Muhammad Ishrat, Cullen, Clare, Umer, Madeha, Carvalho, Andre F., Kloiber, Stefan, Meyer, Jeffrey H., Ortiz, Abigail, Knyahnytska, Yuliya, Husain, M. Omair, Giddens, Justine, Diniz, Breno S., Wang, Wei, Young, Allan H., Mulsant, Benoit H., Daskalakis, Zafiris J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7161279/
https://ncbi.nlm.nih.gov/pubmed/32295565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-020-02553-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados